Telemedicine vs. In-person Delivery of Cognitive Behavioral Treatment of Insomnia: a Mixed Methods Analysis

Completed · Not applicable

Conditions studied: Insomnia Disorder

In brief

Cognitive behavioral therapy for insomnia (CBT-I) has been the 'gold standard' for the treatment of insomnia. There is a need to increase access to treatment, particularly for patients in more rural locations where providers may be scarce. One solution is to utilize telemedicine which is "the use of electronic communications to provide and support health care when distance separates the provider from the patient." So the purpose of the study is to determine if receiving CBT-I by video teleconferencing works just as well as in-person treatment.

Key facts

Study ID

NCT03328585

Run by

University of Pennsylvania

People needed

62

Starts

2017-11-21

Expected to finish

2020-10-01

Last updated by the study team

2020-10-08

Who can join

Age: 21 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Meet current DSM5 criteria for Insomnia Disorder as determined by clinician interview
• ISI score greater than 14, with self-reported duration of insomnia of at least 3 months
• Ability to read and speak English
• Own a personal computer with an internet connection sufficient to utilize the SleepTM and REDCap platform
• BMI less than 30
• Between the ages of 21-50

You may not qualify if…

• Unable or unwilling to provide informed consent
• Individuals with an untreated sleep disorder other than insomnia (Individuals with sleep apnea who are adherent with CPAP treatment (average 4 hours use per night) will be eligible to participate)
• A clinically unstable medical condition as defined by a new diagnosis or change in medical management in the previous 2 months
• Individuals with substance abuse/dependence, bipolar disorder, delirium, dementia, amnestic disorder, schizophrenia, and other psychotic disorders
• Individuals with prominent current suicidal or homicidal ideation
• Unable to perform tests due to inability to communicate verbally, inability to read and write; less than a 5th grade reading level; visual, hearing, or cognitive impairment
• Any use of medications or OTC products that might impact sleep or metabolism

Where it is running

• University of Pennsylvania — Philadelphia, Pennsylvania, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.